The global Burn Care Market is forecasted to grow at a robust Compound Annual Growth Rate (CAGR) of 5.6%, expanding from US$2.46 billion in 2024 to an estimated US$3.35 billion by 2030. This growth is attributed to an increase in burn injuries, advancements in treatment technologies, and rising awareness of burn care.
Within this expanding market, the biologics segment is expected to register the highest CAGR during the forecast period. This is driven by the increasing demand for advanced and effective treatment options for deep and complex burns, as biologics offer targeted healing, minimize complications, and promote tissue regeneration.
Integra LifeSciences Holdings Corporation is recognized as a major player in this market, specifically noted for its broad range of biologics that provide crucial support for severe burns. This market trend indicates a favorable environment for Integra's specialized regenerative technologies, positioning the company to capitalize on the growing demand for advanced burn care solutions.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.